Skip to main content
. 2015 Jun 17;10(6):e0129922. doi: 10.1371/journal.pone.0129922

Fig 3. Propensity score matched hazard ratios of study outcomes among diabetic patients with advanced chronic kidney disease.

Fig 3

Proper oral antidiabetic drugs excluded the patients using alpha-glucosidase inhibitor and/or metformin. ACEIs, angiotensin converting enzyme inhibitors; ARBs, angiotensin II receptor blockers; CAD, coronary artery disease; CCBs, calcium channel blockers; CI, confidence interval; HR, hazard ratio; NSAIDs, non-steroid anti-inflammatory drugs; OADs, oral antidiabetic drugs; TZD, thiazolidinedione.